Atlas market file · Etf · United States
Leverage Shares 2x Long UEC Daily ETFUECG
- Last close
- 4.2813
- Change
- -3.14%
- 96-bar range
- 2.81 – 11.97
- As of
- 13 Aug 2026
Leverage Shares 2x Long UEC Daily ETF is an exchange-traded fund listed as UECG on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 28 weekly closes (-65.05% over the window).
Source rail: Yahoo Finance chart API (UECG). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for UECG. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
UECG public profile
Exchange-traded fund. Leverage Shares 2x Long UEC Daily ETF is connected to current market context, cited company sources and its retained research file.
Leverage Shares 2x Long UEC Daily ETF trades as UECG on NASDAQ. Leverage Shares 2x Long UEC Daily ETF (UECG) has a latest verified close of 4.2813, down 3.14%, dated 13 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. UECG stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Leverage Shares 2x Long UEC Daily ETF today
The Leverage Shares 2x Long UEC Daily ETF-UECG-launched as a Nasdaq-listed instrument designed to deliver twice the daily return of the UEC index, a basket tied to energy and mining. The fund’s mandate is explicit in its SEC filing: a synthetic daily concentrated exposure that resets each trading day, not a buy-and-hold product. The Nasdaq market page shows liquidity and volume, but those figures only reflect the wrapper’s tradability, not the index’s underlying volatility or the fund’s daily compounding mechanics.
UECG’s expense ratio sits at 1.85%, a figure that sounds routine until you remember it’s charged daily on a concentrated product. The fund’s structure means every up-move or down-move is amplified, and the fee compounds alongside the daily reset, turning modest index volatility into a headwind that grows with time. The issuer’s marketing sells a thematic concentrated play, but the filing is the only place you’ll find the daily arithmetic spelled out.
The SEC filing for UECG confirms the fund’s mandate, expense ratio, and issuer, but it offers no insight into the UEC index’s constituents or their concentration. That information sits behind the index methodology, which is not disclosed in the filing itself. The Nasdaq page provides trading data, but the numbers reflect the wrapper’s liquidity, not the index’s composition or the fund’s daily reset drag. If you want to see how the fee compounds, you’ll need to run the fund through FINRA’s Fund Analyzer, which will tell you the cost but not the underlying basket’s risk profile.
To see how UECG trades, head to its Nasdaq market page, where you’ll find daily volume, spreads, and last price, but no indication of the index’s constituents or the fund’s daily reset mechanism in action. The fund’s price action is a reflection of the UEC index’s daily moves, amplified by two, plus the 1.85% fee, which is baked in whether the index rises or falls. The Nasdaq page is a snapshot of the wrapper’s liquidity, not the index’s composition or the fund’s daily arithmetic.
What’s missing? The fund’s SEC filing does not disclose the UEC index’s constituents, weighting, or methodology, so we don’t know the basket’s concentration or sector mix. The Nasdaq page gives trading data, and FINRA’s analyzer gives fees, but neither tells us whether the underlying index’s constituents are aligned with the issuer’s thematic pitch. If the UEC index’s components shift, the fund’s daily concentrated exposure changes with them, but the wrapper’s marketing still sells the same simplified story. The evidence we have confirms the wrapper’s structure and fee, but the index’s composition remains a black box unless the issuer publishes it separately.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
UECG technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on UECG
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep UECG research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
UECG FAQ
What is Leverage Shares 2x Long UEC Daily ETF (UECG)?Leverage Shares 2x Long UEC Daily ETF (UECG) has a latest verified close of 4.2813, down 3.14%, dated 13 Aug 2026. Use this page to check the price chart, company...
Leverage Shares 2x Long UEC Daily ETF (UECG) has a latest verified close of 4.2813, down 3.14%, dated 13 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for UECG?Leverage Shares 2x Long UEC Daily ETF (UECG) has a latest verified close of 4.2813, down 3.14%, dated 13 Aug 2026. It brings the latest available chart, company...
Leverage Shares 2x Long UEC Daily ETF (UECG) has a latest verified close of 4.2813, down 3.14%, dated 13 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. UECG stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the UECG page updated?The UECG public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The UECG public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for UECG?The UECG file starts with Nasdaq Trader and TradingView NASDAQ:UECG. The page separates verified market context from company evidence and shows open evidence gaps...
The UECG file starts with Nasdaq Trader and TradingView NASDAQ:UECG. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on UECG?Yes. The workstation can open UECG, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open UECG, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this UECG page investment advice?No. The UECG page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The UECG page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
UECG
Etf · evidence first